ADVOCATE REDI-CODE BLOOD GLUCOSE MONITORING SYSTEM, MODELS TD-4223E; TD-4223F— 510(k) K072039

Substantially Equivalent

Taidoc Technology Corporation

FDA 510(k) clearance K072039 for ADVOCATE REDI-CODE BLOOD GLUCOSE MONITORING SYSTEM, MODELS TD-4223E; TD-4223F, Substantially Equivalent on 2007-10-03. Applicant: Taidoc Technology Corporation.

Clearance details

Applicant: Taidoc Technology Corporation
Product code: Code NBW
Advisory panel: Clinical Chemistry
Date received: 2007-07-25
Decision date: 2007-10-03
Decision: Substantially Equivalent
Clearance type: Special
Location: San Chung, Taipei, TW

Download summary PDF View on FDA.gov ↗

Adverse events under product code NBW

product code NBW

Death: 18
Injury: 4,740
Malfunction: 42,679
Other: 6
Total: 47,443

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.